• A Redondo, A Martín, L Guardado, A Martín, S Rojas, N Gutiérrez, B Vidriales, M González, J San Miguel, D Caballero. Autologous stemcell transplantation in patients with relapsed or refractory aggressive B-cell lymphoma: influence of prior exposure to rituximab on outcomes. 38th Annual Meeting of the European Group for Blood and Marrow Transplantation. Geneva, Switzerland. 1-4 Abril 2012. Bone Marrow Transplant 47 (supplement 1s): P1155.

  • M Monica, A Martín, J Gayoso, J Briones, I Jarque, R Arranz, I Heras, E Conde, T Bernal, C Grande, J Lopez, D Caballero. Phase II study of Yttrium-90-Ibritumomab Tiuxetan in reduced intensity conditioning (RIC) allogeneic transplant in relapsed or refractory aggressive B-cell lymphoma: a GEL/TAMO phase II clinical trial. 16th Congress of the European Hematology Association, London, United Kingdom, Junio 9-12, 2011. Haematologica 2011; 96 (suppl 2): abstr 992.

  • J. Calvo, A. Pascual, I. Heras, J. de la Rubia, R. Varela, E. González, R. Carrión, A. León, R. Arranz, E. Donato, M. Pascual, R. Andreu, M. Rodríguez, A. Martin, S. Nistal, J. Sancho, J. Briones, J. Rodriguez, A. Salar, E. Pardal, S. Duran, J. García, M. Caballero.On behalf of the GEL/TAMO Cooperative Group. Results and prognostic factors affecting survival in patients with relapsed diffuse large B-cell non-Hodgkin’s lymphoma progressing after autologous stem-cell transplantation. 10th International Conference on Malignant Lymphoma (Lugano, Switzerland; Junio 04-07, 2008).
  • J.M. Calvo-Villas, A. Pascual, I. Heras, J. de la Rubia, R. Varela, M.J. Ramirez, R. Carrión, J. Sarra, M.J. Pascual, M.J. Rodríguez-Salazar, E. Donato, A. Martin, S. Nistal, A. Salar, R. Andreu, J. Sancho, J. Briones, R. Arranz, J.N. Rodriguez, E. Pardal, S. Duran, F.J. Peñalver, J. García-Marco, E. González-Barca, M.D. Caballero. On behalf of the GEL/TAMO Cooperative Group. Outcome of patients with Diffuse Large B Cell Lymphoma relapsing after an Autologous Stem Cell Transplant (ASCT). Abstract 0760 for a POSTER presentation during the 13th Congress of the European Hematology Association (EHA).
  • J.M. Calvo-Villas, E. Conde, A. Pascual, I. Heras, R. Varela, J. de la Rubia, M. J. Ramirez, R. Carrión, C. Panizo, A. Martin, M. J. Rodríguez-Salazar, M.J. Pascual, E. Donato, S. Nistal, A. Salar, R. Andreu J. Sancho, J. Briones, R. Arranz, J. N. Rodriguez, E. Pardal, S. Duran, F. J. Peñalver, J. García-Marco, R. Mataix, J. A. Queizán, E. González-Barca, M. D. Caballero. On behalf of the Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea Spanish Cooperative Group. Outcome of patients with Diffuse Large B Cell Lymphoma relapsing after an Autologous Stem Cell Transplant (ASCT). Abstract 2593 for poster presentation at the 2008 Annual Meeting of the American Society of Hematology
  • Salar A, Domingo-Domenech E, Estany C, Canales M, Servitge O, Gallardo F, Fraile G, Montalbán C. First-line treatment with rituximab combined with intravenous or oral fludarabine for patients with extranodal Mucosa Associated Lymphoid Tissue (MALT) lymphoma. Annual Meeting American Society of Hematology 2008
  • Martin A, Conde E, Arnan M, Canales MA, Deben G, Andreu R, Salar A, Garcia-Sanchez P, Nistal S, Requena MJ, Donato EM, Gonzalez JA, Leon A, Ruiz C, Grande C, Arranz R, Duran S, Ortegon S, Rodriguez JN, Sandoval V, Andreu MA, Bernal T, Hernandez MT, Gonzalez-Barca E, Caballero MD. R-ESHAP as Salvage Therapy for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Spanish GEL-TAMO Multicenter Study. Blood (ASH Annual Meeting Abstracts), Nov 2007; 110: 3438
  • Jose Rodriguez, Eulogio Conde, Antonio Gutierrez, Reyes Arranz, Angel Leon, Julian Marin, Maurizio Bendandi, Carmen Albo, Maria Dolores Caballero. Front-Line Consolidation with Autologous Stem Cell Transplantation in Patients with Nodal Aggressive Peripheral T-Cell Lymphoma (PTCL). A Prospective Study of the GEL-TAMO.>48th Annual Meeting American Society of Hematology. Diciembre 10-13. 2006. Orlando. Florida.Blood 2006, 108:697a. ISSN 0006-497
  • Jose Rodriguez, Eulogio Conde, Antonio Gutierrez, Juan Carlos Garcia-Ruiz, Juan Jose Lahuerta, Maria Rosario Varela, Encarnacion Perez-Equiza, Julian Marin, Carmen Albo, Maria Dolores Caballero. Front-Line Autologous Stem Cell Transplantation (ASCT) in Primary Mediastinal Large B-Cell Lymphoma: The GEL-TAMO Experience.48th Annual Meeting American Society of Hematology. Diciembre 10-13. 2006. Orlando. Florida.Blood 2006, 108:870a. ISSN 0006-4971
  • David Serrano, Pascual Balsalobre, Rafael Carrion, Javier Anguita, Pilar Miralles, Juan Berenguer, Ismael Buño, Alfonso Gomez-Pineda, Rosario Varela, Eulogio Conde, Ildefonso Espigado, Lourdes Escola, Pascual Fernandez, Pedro Sanchez-Godoy, Javier Loscertales, Josep-Maria Ribera, Jose L. Diez-Martin. Comparative Study of Autologous Stem Cell Transplant (ASCT) in HIV-1 Positive (HIV+) on Haart and HIV-1 Negative (HIV-) Non Hodgkin Lymphoma (NHL) Patients. Annual Meeting American Society of Hematology. Diciembre 10-13. 2006. Orlando. Florida. Blood 2006, 108:872a. ISSN 0006-4971
  • Pascual Balsalobre, David Serrano, Alessandro Re, Anne Rosselet, Eulogio Conde, Josep-Maria Ribera, Bernardino Allione, Gaelle Guillerm, Philippe Genet, Ildefonso Espigado, Ann E. Hunter, Marcus Hentrich, Pierre Biron, Agostoin Ferrant, Dirk Meyer, Carmen Canals, Goli Taghipour, Jose L. Diez-Martin, Anna Sureda. Autologous Stem Cell Transplantation (ASCT) in HIV Associated Lymphoma (HIV-Ly) Patients: The EBMT Lymphoma Working Party (EBMT-LWP) Experience. 48th Annual Meeting American Society of Hematology. Diciembre 10-13. 2006. Orlando. Florida. Blood 2006, 108:865a.ISSN 0006-4971
  • E. Conde, R. Arranz, J. Rodríguez, C. Grande, M. Gandarillas, J. L. Bello, C. Albo, ML Gutierrez, S. Garzón, M. T. Hernández, J. A. García-Vela, P. Fernández, María L. Amigo, D. Caballero. Treatment Stratification According to Early Response to Mega-CHOP, Based on CT and Gallium-67 Scan (G67S) with or without IFE Salvage Therapy Followed by Autologous Stem Cell Transplant (PBSCT) in Patient with Poor Prognosis Aggressive Lymphoma. 11th Congress of the European Hematology Association (EHA). Junio 15-18. 2006. Amsterdam, the Netherlands. Haematologica. 2006; 91 (S1):261. ISSN 0390-6078. Haematologica. 2006;91:260. ISSN 0390-6078
  • E Conde, R Arranz, J Rodriguez, M Gutierrez, C Grande, M Gandarillas, C Albo, J Bello, S Garzón, M Hernández, J García-Vela, P Fernández, M Amigo, D Caballero. Therapy according to early response to Mega-CHOP based on CT and Gallium67 Scan with / without IFE salvage therapy followed by peripheral autologous stem cell Transplant in poor prognosis aggressive lymphoma. A preliminary report from a porspective GELTAMO trial. 32nd Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT). Hamburg, Germany, 19-22 Marzo 2006. Bone Marrow Transplant 2006; 37:S233-234
  • D Serrano, P Balsalobre, R Carrión, J Anguita, P Miralles, J Berenger, I Buño, A Gomez-Pineda, R varela, E Conde, L Escoda, P Fernández, JL Diez-Martín. Comparative study of autologous stem cell transplantation in VIH-1 positive on HAART and VIH-1 negative non-Hodgkin lymphoma patients. 32nd Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT). Hamburg, Germany, 19-22 Marzo 2006. Bone Marrow Transplant 2006; 37:S235-236
  • E. Conde, R. Arranz, J. Rodríguez, M.L. Gutiérrez, C. Grande, M. Gandarillas, C. Albo, S. Garzón, M.T. Hernández, J.A. García Vela, P. Fernández Abellán, J.L. Bello, M.L. Amigo and MD. Caballero. On behalf on the GEL/TAMO Group. Treatment stratification according to early response to Mega-CHOP, based on CT and Gallium 67 Scan (G67S) with or without IFE salvage therapy followed by peripheral autologous stem cell transplant (PBSCT) in patient with por prognosis aggressive lymphoma. A preliminary report from a prospective GEL/TAMO trial. EBMT Annual Meeting. Hamburg. Marzo 19-22, 2006

  • J. Rodríguez, D. Caballero, A. Gutiérrez, M. Gandarillas, A. León, Jesús Ojanguren, A. Sureda, A. Lopez-Guillermo, D. Carrera, M. Bendandi, R. Arranz, J. Moraleda, J. Mª Ribera, C. Albo, A. Morales, J. C. García, P. Fernández, G. Cañigral, J. Bergua, E. Conde. For Spanish Group GELTAMO Prolonged Survival in Patients with angioimmunoblastic T-Cell Lymphoma (AIL) after High-Dose Chemotherapy and Autologous Stem Cell Transplantation (ASCT). The GELTAMO experience. 47 Annual Meeting American Society of Hematology. Diciembre 10-13. 2005. Atlanta. Georgia.
  • E. Conde, R. Arranz, J. Rodríguez, María L. Gutiérrez, C. Grande, M. Gandarillas, C. Albo, J. L. Bello, S. Garzón, M. T. Hernández, J. A. García-Vela, P. Fernández, María L. Amigo, D. Caballero. Treatment Stratification According to Early Response to Mega-CHOP, Based on CT and Gallium67 Scan (G67S) with or without IFE Salvage Therapy Followed by Peripheral Autologous Stem Cell Transplant (PBSCT) in Patient with Poor Prognosis Aggressive Lymphoma. A Preliminary Report from a Porspective GELTAMO Trial. 47 Annual Meeting American Society of Hematology. Diciembre 10-13. 2005. Atlanta. Georgia.
  • J.L. Diez-Martin, R. Carrión, J. Anguita, P. Balsalobre, P. Miralles, J. Berenguer, I. Buno, A. Gómez-Pineda, E. Conde, R. Varela, J. Mª Ribera, I. Espigado, L. Escoda, J. Loscertales, D. Serrano. On behalf of Spanish Groups GELTAMO-GESIDA. Does Highly Active Anti-Retroviral Therapy (HAART) Delay Myeloid, Engraftment after Autologous Stem Cell Transplant (ASCT) in HIV Associated Lymphoma (HIV+Ly) Patients?. 47 Annual Meeting American Society of Hematology. Diciembre 10-13. 2005. Atlanta. Georgia.
  • J. Rodríguez, M. Caballero, A. Gutierrez, J. Marín, R. Arranz, J. Lahuerta, J. Sierra, A. López-Guillermo, A.. Sureda, E. Carrerras, A. Leon, A. Fernández de Sevilla, J. Zuazu, M. Sanz, G. García-Laraña, M. Bendandi, R. Varela, M Gandarillals, J. San Miguel, E. Conde, “Long-term follow-up of autologous stem cell transplantatios (ASCT) in patients with peripheral T-cell lymphoma (OTCL)”: the Spanish Lymphoma Cooperative Group (GEL-TAMO) experience 9 th International Conference on malignat Lymphoma. Lugano. Switzzerland. Junio 2005.
  • J. Rodríguez, M. Caballero, A. Gutierrez, J. Marín, R. Arranz, J. Lahuerta, J. Sierra, A. López-Guillermo, A.. Sureda, E. Carrerras, A. Leon, A. Fernández de Sevilla, J. Zuazu, M. Sanz, G. García-Laraña, M. Bendandi, R. Varela, M Gandarillas, J. San Miguel, E. Conde, Hematology-Oncology, On behalf of Spanish Lymphoma Cooperative Group (GEL-TAMO) Spain. “Front-line autologous stem cell transplantation (ASCY) improves the outcome of peripheral T-cell lymphoma (OTCL) in first remissión patient presenting with unfavourable prognostic factor” . 9 th International Conference on Malignant Lymphoma. Lugano Switzerland. Junio 2005.
  • D. Caballero, R. Arranz, J. Rodríguez, ML Gutierrez, C. Grande, M Gandarillas, C. Albo, JL Bello, S. Garzón MT Hernández, JA García-Vela, P. Fernández, ML Amigo, E. Conde. “Treatment stratification According to early response to mega-CHOP, Vases on CT and Gallium-67 scan (G67S) with or without IFE salvage therapy followed by Peripheral Autologous stem cell . Preliminary report front a prospective GELTAMO trial.” 9 th International Conference on Malignant Lymphoma. Lugano Switzerland. Junio 2005
  • M. Constans, A- Sureda, R. Arranz, MD. Caballero, JJ. Lahuerta, JC. Hernández-Boluda,MJ Vidal, J. García.Laraña, J. Rifón, JM Ribera, P. Fernández-Abellán, JM Moraleda, MR Bernal, MV Mateos, M Martín-Mateos, R. Córdoba, J. García-Conde, J. Sierra, Eulogio Conde por Sapnish Cooperative (GEL/TAMO)“Pronostic Factor and Long-Term Outcome for Patients with Hodgkin´s Lymphoma Who Relapse after an Autologous Stem Cell Transplantation”XLVI Abstract Reunión anual American Society of Hematology San Diego-California 4-7 Diciembre 2004.
  • M. Constans, A- Sureda, R. Arranz, MD. Caballero, JJ. Lahuerta, JC. Hernández-Boluda, MJ Vidal, J. García.Laraña, J. Rifón, JM Ribera, P. Fernández-Abellán, JM Moraleda, MR Bernal, MV Mateos, M Martín-Mateos, R. Córdoba, J. García-Conde, J. Sierra, E. Conde por Sapnish Cooperative (GEL/TAMO) “Secondary Malignancies after autologous Stem Cell trasplantation for Hodgkin´s Lymphoma: Incidence and Analysis Risk Factors”XLVI Abstract Reunión anual American Society of Hematology San Diego-California 4-7 Diciembre 2004.
  • J. Rodríguez, M D. Caballero, A. Gutierrez, M Gandarillas, J. Sierra, A. López-Guillermo, A. Sureda, J. Zuazu, jJ. Marín, R. Arranz, E. Carreras, A. León, A. Fernñandez de Sevilla, JF San Miguel, E. Conde.Autologous Stem Cell Transplantation in Induction Failure Patients with Peripheral T.Cell Lymphoma: The GEL/TAMO Esperience. 45 th Annual Meeting of the American Society of Hematology- Diciembre 2003. San Diego-California
  • J. L. Diez-Martín, P. Balsalobre, P Miealles, A Gómez-Pineda, R. Carrión, I. Buño, S Resino, E. Conde, JM Ribera, D. Serrano, J. Beremguer GEL/TAMO and GESDIDA“Efficacy of autologous stem cell transplant in aids-relalted lymphoma patients”30th Annual Meeting of the European Group for Blood and Marrow Transplantation. Barcelona 28-31 Marzo 2004.
  • M. Constans, A. Sureda, R. Arranz, MD Caballero, JJ. Lahuerta, J. Hernández-Boluda, M. Vidal, G. García-Laraña, J. Riffón, J. Ribera, P. Fernández-Abellán, J. Moraleda, M. Bernal, M. Mateos, M. Martín-Mateos, R. Córdoba, J. García-Conde, J. Sierra, E. Conde, Grupo GEL/TAMO“Prognostic factors effecting long-term outcome in patients with Hodgkin Lymphoma who relapse after autologous stem cell transplantation”30th Annual Meeting of the European Group for Blood and Marrow Transplantation. Barcelona 28-31 Marzo 2004.
  • J. L. Diez-Martín, P. Balsalobre, P Miealles, A Gómez-Pineda, R. Carrión, I. Buño, S Resino, E. Conde, JM Ribera, D. Serrano, J. Beremguer GEL/TAMO and GESDIDA“Efficacy of autologous stem cell transplant in aids-relalted lymphoma patients” Annual Meeting of the European Group for Blood and Marrow Transplantation. Barcelona 28-31 Marzo 2004.
  • F Marco, D. Caballero, R Arranz, JJ Lahuerta, A. Sureda, J García-Laraña, M Gandarillas, R Cabrera, A León, MJ Muruzabal, J Zuazu, C Albo, A Bermudez, J Marín, JM Moraleda, MR Varela, E Carreras, A Fernández de Sevilla, J Rifón, C Campo, MJ Pascual, JC García, J García-Conde, D Carrera, K Pérez-Equiza, JL Bello and E Conde. Secondary neoplasms after autologous transplantation in patients with lymphoma. The experience of GEL/TAMO Spanish cooperative group.43rd Annual Meeting of American Society of Hematology. Orlando, Florida. Diciembre 2001.
  • Rodriguez J, Caballero D, Gutierrez A, Sierra J, López-Guillermo A, Marín J, Sarra J, Lahuerta JJ, Rifón J, Conde E. Results of high dose chemotherapy and autologous stem cell transplantation in patients with pheripheral T-cell lymphoma. The Spanish Lymphoma Cooperative Group esperience (GEL/TAMO). 43rd Annual Meeting of ASH. Diciembre. 2001. Orlando. Florida.
  • JL Diez-Martín, P. Balsalobre, R. Carrión, A. Gómez-Pineda, P Miralles, J. Berenguer, I. Bruno, E. Conde, JM. Ribera, D. Serrano BMT Long Term Survival after Autologous Stem Cell Transplant (ASCT) in AIDS Relaatec Lymphoma Patients. 45 th Annual Meeting of the American Society of Hematology- Diciembre 6-9 San Diego-California. Blood Journal of the american society hematology. ISSN 0006-4971 Ed. Philadelphia.USA
  • M.D.Caballero, J.P.Simon, J.J.Lahuerta, J.Sierra, J.Marin, M.Gandarilla, M.V.Mateos, A.Iriondo, R.Arranz, J.Zuazu, V.Rubio, A.FernandezSevilla, E.Carreras, J.GarciaConde, J.GarciaLaraña, C.Grande, J.Rifón, C.Perez-Equiza, R.Varela, J.M.Moraleda, JC García, C Albo, R Cabrera, JF San Miguel and E. Conde for the Grupo Español de Linfomas/Trasplante autólogo de Médula Ósea Spanish Cooperative Group. High dose therapy in large cell lymphoma: analysis of prognostic factors in 452 patients from the gel-tamo spanish registry. 43rd Annual Meeting of American Society of Hematology. Orlando, Florida. Diciembre 2001.
  • A. Sureda, R. Arranz, A. Iriondo, E. Carreras, JJ. Lahuerta, J. García-Laraña, I. Jarque, MD. Caballero, C. Ferrà, A. López, J. García-Laraña, R. Cabrera, D. Carrera, MD. Ruiz-Romero, A. León, J. Rifón, J. Díaz-Mediavilla, R. Mataix, M. Morey, JM. Moraleda, A. Altés, A. López-Guillermo, J. de la Serna, JM. Fernández-Rañada, J. Sierra, E. Conde for the Spanish Cooperative Group GELTAMO. Autologous Stem-Cell Transplantation for Hodgkin’s Disease: Results and Prognostic Factors in 494 patients from the Grupo Español de Linfomas/Trasplante Autólogo de Médula Ósea Spanish Cooperative Group. 27th Annual Meeting European Group for Blood and Marrow Transplantation and 17th Meeting of the Nurses Group. Maastricht. The netherlands. Marzo 2001
  • Caballero D, Pérez-Simón JA, García-Laraña J, Gandarillas M, Marín J, Lahuerta JJ, Arranz R, Rubio V, García-Conde J, Zuazu J, Vázquez L, Montserrat E, Grañena A, Sanz MA, Mataix R, Maldonado J, Rifón J, Sierra J, Carrera D, Moraleda JM, Conde E. High dose therapy in large cell lymphoma: analysis of prognostic factors in 452 patients of GEL-TAMO Restry.27th Annual Meeting European Group for Blood and Marrow Transplantation and 17th Meeting of the Nurses Group. Maastricht. The netherlands. Marzo 2001
  • Guglielmi C, Gómez F, Conde E. Prognostic evaluation in adults with diffuse large B-cell lymphoma treated with autologous stem cell transpalntation at first sensitive relapse. 27th Annual Meeting European Group for Blood and Marrow Transplantation and 17th Meeting of the Nurses Group. Maastricht. The netherlands. Marzo 2001

  • Rodriguez J, Caballero D, Solano C, Lahuerta JJ, Arranz R, Sureda A, Marín J, García-Laraña J, López-Guillermo A, San miguel J, Conde E. High-dose chemotherapy (HDC) and autologous stem cell transplantation (ASCT) in patients with primary refractory aggressive non-Hodgkin´s lymphoma. 27th Annual Meeting European Group for Blood and Marrow Transplantation and 17th Meeting of the Nurses Group. Maastricht. The netherlands. Marzo 2001.

  • Sureda A, Arranz R, García-Conde J, Caballero D, Iriondo A, Jarque I, López-Guillermo A, León A, Carrera D, López A, Ruiz MD, Díaz-Mediavilla J, Grañena A, Hernández-Navarro F, Mataix R, Moraleda JM, Albo C, Pérez-Equiza K, Sierra J, Fernández-Rañada JM, Solano C, Regadera A, Carreras E, Conde E. High dose therapy with autologous stem cell transplantation in primary refractory Hodgkin´s disease: Experience of the Spanish GEL/TAMO group. 27th Annual Meeting European Group for Blood and Marrow Transplantation and 17th Meeting of the Nurses Group. Maastricht. The netherlands. Marzo 2001.
  • A. Sureda, R. Arranz, R. Cabrera, J. García Laraña, A. Iriondo, JJ. Lahuerta, A. León, A. López, R. Mataix, JM. Moraleda, MD Ruiz-Romero, E. Carreras, J. García-Conde, I. Jarque, MD. Caballero, C. Ferrà, D. Carrera, J. Rifón, J. Díaz.-Mediavilla, M. Morey, A. López-Guillermo, J. De la Serna, JM. Fernández Rañada, J. Sierra, E. Conde for the GEL/TAMO Spanish cooperative group. Secondary Malignancies risk after Autologous stem cell transplantation (ASCT) for Hodgkin`s disease (HD). A retrospective analysis from the GEL/TAMO. 26 th Annual EBMT Meeting. Innsbruck, Austria. Marzo 2000. 42 nd ASH Annual Meeting. San Francisco. Diciembre 2000.
  • C. Sanz-Rodríguez, A. Sanchez, F. Rodríguez, M. Gandarillas, E. Conde, R. Arranz. Chemotherapy plus Interferon-2b vs. High-dose therapy for response consolidation in low grade non-Hodgkin’s lymphoma: Results of a retrospective case control study.On behalf of the GEL/TAMO Spanish Cooperative Group and the LNH-PRO Study Group, Spain. 42nd Annual Meeting ASH. San Francisco, California. Diciembre 2000.
  • C. Guglielmi, F. Gómez, E. Conde. Factors influencing the outcome of autologous stem cell transplant at first sensitive relapse in 247 adults with diffuse large B-cell Lymphoma. Biotecnologie. Cellulari ed Ematologia, University La Sapiensa, Roma; Unite d’Information Médicale, Unité de Biostatistiques et d’Evaluation des Thérapeutiques, Centre Léon-Bérard, Lyon, Frande; and The GEL/TAMO Spanish Cooperative Group. 42nd Annual Meeting ASH. San Francisco, California. Diciembre 2000.
  • E. Conde, J García-Conde, D. Caballero, R. Arranz, J. Sierra, M. Gandarillas, JC. García, MJ. Vidal, JJ. Lahuerta, A. López-Guillermo, C. Albo, J. García-Laraña, F. Marco, MR. Varela, J. Rifón, J. Zuazu, A. Fernández Sevilla, C. Herrera. Autologous stem cell transplantastion (ASCT) for mediastinal large B-cell with sclerosis (MLBCL). 42nd Annual Meeting ASH. San Francisco, California. Diciembre 2000.
  • A. Salar, J. Sierra, D. Caballero, J. Marín, JJ Lahuerta, J. García-Conde, R. Arranz, A. León, J. Zuazu, J. García-Laraña, JC. García, MA. Sanz, A. Grañena, E. Montserrat, E. Conde. Autologous stem cell transplantation for clinically aggressive non-Hodkin’s Lymphoma: The role of preparative regimen. The GEL/TAMO Spanish Cooperative Group. Fiveth Annual Meeting of the European Haematology Association: Birmingham, UK, Junio 2000.
  • E. Conde, J. Zuazu, A. López-Guillermo, J. García-Laraña, R. Arranz, J. Sierra, JJ. Lahuerta, D. Caballero, J. García-Conde, M. Gandarillas, MJ. Vidal, A. Grañena, J. Rifón, A. Torres, F. Hernández Navarro, JL. Bello, A. Iriondo. Autologous stem cell transplantation for lymphoblastic lymphoma. Forty-first Annual Meeting of American Society of Hematology. New Orleans, Diciembre 1999.

  • E. Conde et al. High-Dose therapy and autologous stem cell transplantation in 56 patients with mantle cell lymphoma. VII International Conference on malignant lymphoma. Lugano, Switzerland. Junio 1999.
  • E. Conde et al. High-Dose therapy and autologous stem cell transplantation (ASCT) in 210 patients with follicular lymphoma (FL). VII International Conference on malignant lymphoma. Lugano, Switzerland. Junio 1999.
  • MD. Caballero et al. High dose therapy with autologous stem cell support in 366 patients with large cell lymphoma. A retrospective analysis of the GELTAMO Spanish Cooperative Group. VII International Conference on malignant lymphoma. Lugano, Switzerland. Junio 1999.
  • A. Sureda, R. Arranz, A. Iriondo, E. Carreras, J. Zuazu, JJ. Lahuerta, et al. High dose therapy with autologous stem cell transplantation in hodgkin's disease in first relapse: Experience of the Spanish Gel/tamo group. Fourth Meeting of the European Haematology Association: Barcelona, Junio 1999.
  • A. Sureda et al. Autologous stem cell transplantation (ASCT) in Hodgkin's Disease (HD) after first relapse: Experience of the Spanish GELTAMO Group. 25 th Annual EBMT Meeting. Hamburg, Germany. Marzo 1999.
  • A. Sureda et al. Autologous stem cell transplants (ASCT) for Hodgkin's Disease (HD): Results and prognostic factors in 495 patients. Experience of the GELTAMO Spanish Group. 25 th Annual EBMT Meeting. Hamburg, Germany. Marzo 1999.
  • E. Conde et al. Autologous stem cell transplantation (ASCT) for Mantle cell Lymphoma (MCL). The Experience of the GELTAMO Spanish Group. 25 th Annual EBMT Meeting. Hamburg, Germany. Marzo 1999.
  • JJ. Lahuerta et al. Autologous stem cell transplantation (ASCT) for Follicular Lymphoma (FL). The Experience of the GELTAMO Spanish Group. 25 th Annual EBMT Meeting. Hamburg, Germany. Marzo 1999.
  • MD. Caballero et al. High dose therapy with autologous stem cell support in 366 patients with large cell lymphoma. A retrospective analysis of the GELTAMO Spanish Cooperative Group. 25 th Annual EBMT Meeting. Hamburg, Germany. Marzo 1999.
  • E. Conde et al. Autologous stem cell transplantation for mantle cell lymphoma. The experience of the GELTAMO Spanish Cooperative Group.> 40th Annual Meeting ASH. Miami Beach, Florida. Diciembre 1998.
  • E. Conde et al. Autologous stem cell transplantation for follicular lymphoma. The experience of the GELTAMO Spanish Cooperative Group. 40th Annual Meeting ASH. Miami Beach, Florida. Diciembre 1998.
  • F. Hernandez. Trasplante en Linfomas. Reunión de la Asociación de Hematología de Costa Rica. Junio 1998.
  • A. Sureda et al. High-risk Hodgkin's disease. Round Table: conventional vs agressive therapy. In advanced patients. 24 th Annual EBMT Meeting. Courmayeur, Italy. Marzo 1998.
  • E. Conde et al. Autologous stem cell transplantation for mantle cell lymphoma. The experience of the GEL/TAMO Spanish Cooperative Group. 39th Annual Meeting. San Diego, California. Diciembre 1997.
  • JJ. Lahuerta et al. High-dose cyclophosphamide, BCNU and VP-16 (CBV) supported with a second autologous hemopoietic transplant (Tx) in multiple mieloma (MM) chemosensitive to melphalan 200 mg/m2. An interum report. 39th Annual Meeting ASH. San Diego, California. Diciembre 1997.
  • D. Caballero (Por el Grupo GEL/TAMO). Linfomas de Bajo Grado. Modalidades Terapéuticas. En III Congresso Nacional das Unidades de Oncologia dos Hospitais distritais. 17 - 19 de Abril, 1997. Póvoa de Varzim. Portugal.
  • A. Sureda, R. Mataix, F. Hernández-Navarro, I. Jarque, JJ. Lahuerta, JF. Tomás, S. Brunet, D. Caballero, E. Conde, A. León, MN. Fernández, A. López, J. Maldonado, E. Bengoechea, M. Callís, D. Carrera, J. García.-Conde, J. García-Laraña, JM. Moraleda, M. Morey, J. Rifón, J. Sierra, A. Torres, A. Domingo-Albós. Autologous stem cell transplantation in first complete remission for poor prognosis Hodgkin's disease: A retrospective study from the Spanish cooperative Group (GEL/TAMO). Hematology Department, Hospital "Santa Creu i Sant Pau" (Barcelona), Spain. 23rd Annual Meeting of the EBMT. Aix-Les-Bains. France, Marzo 1997.
  • JJ. Lahuerta-Palacios, C. Grande, J. de la Serna, J. Bargay, R. Bornstein, MC. Ortiz, R. Toscano, S. Larregla. High-dose cyclophosphamide, BCNU and VP-16 (CBV) supported with a second autologous hemopoietic trasnsplant (Tx) in multiple myeloma (MM) chemosensitive to melfalan 200 mg/m2 (MEL200). First interim report. (Spanish Cooperative Group GEL/TAMO and GETH study) . Hematology Units, Hospital "12 de Octubre" (Madrid) and Hospital "Son Dureta (Palma de Mallorca), Spain. Second Meeting of the European Hematology Association. Mayo 29-Junio 1, 1996- Paris, France.
  • A. Domingo, A. Sureda, A. Iriondo, JF. Tomás, E. Bengoechea, D. Caballero, J. Zuazu, F. Hernández, J. García-Laraña, J. Sierra, A. Torres, E. Rocha, C. Solano, R. Mataix, J. Maldonado, A. León, J. Besalduch, S. Brunet, J. Rifón, MA. Sanz, JM. Fernández, E. Conde, J. Odriozola, J. García-Conde. Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea (GEL/TAMO). High dose chemo/radiotherapy with autologous rescue for Hodgkin's disease patients in 2nd or 3rd complete remision. 21st Annual Meeting of the EBMT. Davos. Switzerland, Marzo 1995.
  • A. Domingo, A. Sureda, A. Iriondo, JF. Tomás, A. León, R. Mataix, MA. Sanz, E. Bengoechea, D. Caballero, F. Hernández, J. García-Laraña, J. Sierra, A. Torres, E. Rocha, C. Solano, J. Maldonado, J. Besalduch, S. Brunet, J. Rifón, JM. Fernández, E. Conde, J. Odriozola, J. García-Conde. Grupo Español de Linfomas/Trasplante Autólogo de Médula Osea (GEL/TAMO). High dose chemo/radiotherapy with autologous transplantation for bad prognosis Hodgkin's disease patients in 1st complete remission. 21 st Annual Meeting of the EBMT. Davos. Switzerland, march 1995.
  • J. Sierra, E. Conde, J. García-Laraña, A. Iriondo, A. Domingo, J. Marín, D. Caballero, F. Martínez, A. León, J. García-Conde, F. Hernández, JC. Reverter, D. Carrera, C. Richard, J. Zuazu, J. Baro, E. Rocha, J. Díaz Mediavilla, C. Rozman, E. Montserrat. Frozen vs. non-frozen bone marrow for autologous transplantation in lymphomas: A Comparative study from the Spanish GEL/TAMO Cooperative Group. Fifth International Conference on Malignant Lymphoma. Lugano. Swizerland. Junio1993.
  • E. Conde, J. Sierra, A. Iriondo, A. Domingo, J. García-Laraña, J. Marín, D. Caballero, F. Martínez, A. león, J. García-Conde, F. Hernández, D. Carrera, R. Mataix, J. Zuazu, B. Cuesta, J. Díaz Mediavilla, J. Lahuerta, C. Richard, J. Baro, E. Montserrat. Prognostic factors in patients who received autologous bone marrow transplantation for non-Hodgkin's lymphoma. Report of 104 patients from the Spanish Cooperative Group GEL/TAMO. Fifth International Conference on Malignant Lymphoma. Lugano. Swizerland. Junio 1993.
  • J. Sierra, E. Conde, J. García-Laraña, J. Lahuerta, A. Iriondo, A. Domingo, J. Marín, D. Caballero, F. Martínez, A. León, J. García-Conde, F. Hernández, C. Solano, D. Carrera, C. Richard, J. Zuazu, J. Baro, J. Rifón, J. Díaz Mediavilla, C. Rozman, E. Montserrat: Autologous bone marrow transplantation for non-Hodgkin's lymphoma in first remission. Fifth International Conference on Malignant Lymphoma. Lugano. Swizerland. Junio 1993.
  • A. Domingo-Albós, A. Sureda, A. Iriondo, J. Odriozola, E. Montserrat, D. Caballero, E. Rocha, J. Bengoechea, J. García-Conde, J. García-Laraña, E. Conde, S. Brunet. Autologous bone marrow transplantation in Hodgkin's disease in complete remission. A report from the Spanish Group of Lymphoma. 19th Annual Meeting of the European Group for Bone Marrow Transplantation. Garmisch-Partenkirchen. Germany. January 1993.
  • J. Baro, C. Richard, J. Sierra, J. García-Conde, J. García-Laraña, E. Rocha, C. Solano, D. Caballero, D. Carrera, A. León, J. Zuazu, F. Martínez, A. Domingo, F. Hernández, J. Marín, A. Iriondo, E. Conde, E. Montserrat: Autologous bone marrow transplantation in adult lymphoblastic lymphoma. 18th Annual Meeting of the Leuropean Group for Bone Marrow Transplantation. Stockholm. Sweden. Mayo 1992.
  • E. Conde, J. Sierra, A. Iriondo, A. Domingo, J. García-Laraña, J. Marín, D. Caballero, F. Martínez, A. León, J. García-Conde, F. Hernández, D. Carrera, J. Zuazu, B. Cuesta, J. Díaz Mediavilla, J. Lahuerta, C. Richard, J. Baro, E. Montserrat. Autologous bone marrow transplantation for non-Hodgkin's lymphoma. Report of 98 patients from the Spanish Cooperative Group. 18th Annual Meeting of the European Group for Bone Marrow Transplantation. Stockholm. Sweden. Mayo 1992.

Nuestro sitio web utiliza cookies propias y de terceros para mejorar nuestros contenidos y servicios mediante el análisis de sus hábitos de navegación. Al aceptar el presente aviso entendemos que da su consentimiento a nuestra Política de cookies.

  Aceptar Política de cookies